AMGEN SINGAPORE MANUFACTURING PTE

Company Introduction:

Company Type: Factory (Manufacturing Plant)

Amgen Singapore Manufacturing Pte Ltd is a significant biopharmaceutical manufacturing facility located in Singapore. It serves as a vital part of Amgen Inc., a leading global biotechnology company dedicated to discovering, developing, manufacturing, and delivering innovative human therapeutics.

This Singapore site is instrumental in the large-scale production of Amgen's innovative medicines, particularly biologics, which are crucial for treating serious illnesses worldwide. The facility leverages advanced manufacturing technologies and operates under stringent quality control standards to ensure the safety, efficacy, and consistent supply of its pharmaceutical products. It plays a key role in Amgen's global supply chain and manufacturing network, contributing to the company's mission of serving patients.

AMGEN SINGAPORE MANUFACTURING PTE primarily manufactures biopharmaceutical products. The key products produced at this facility include:

Denosumab (marketed globally as Prolia and Xgeva)

Evolocumab (marketed globally as Repatha)

This facility is a state-of-the-art biologics manufacturing plant that produces active pharmaceutical ingredients for Amgen's global supply chain.